Related Experiment Video
Updated: Jun 19, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Erlotinib and nonsmall cell lung cancer with brain metastases: a case study with a complete and prolonged response
A Mairovitz1, E Staub, H Le Floch
1Service de Pneumologie, HIA de Percy, 101, Avenue Henri-Barbusse, BP 406, 92141, Clamart Cedex, France. alexamairovitz@hotmail.com
Abstract:
The prognosis of stage IV nonsmall cell lung cancer, in particular with brain metastases, is extremely poor. The impact of targeted therapy, in particular erlotinib, on patient survival has still not been determined. The authors report the case of a patient diagnosed with nonsmall cell lung cancer with bone and brain metastases. The patient presented a complete cerebral response for 17 months with erlotinib prescribed as a third line therapy.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers